التفاصيل البيبلوغرافية
العنوان: |
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. |
المؤلفون: |
Meyers, Paul A., Federman, Noah, Daw, Najat, Anderson, Peter. M., Davis, Lara E., Kim, AeRang, Macy, Margaret E., Pietrofeso, Angela, Ratan, Ravin, Riedel, Richard F., Trucco, Matteo, Breitmeyer, James B., Toretsky, Jeffrey A., Ludwig, Joseph A. |
المصدر: |
Journal of Clinical Oncology; 11/1/2024, Vol. 42 Issue 31, p3725-3734, 12p |
قاعدة البيانات: |
Supplemental Index |